“Benefit of Using Renal Sodium-Glucose Cotransporter Inhibitors 2 (iSGLT-2) in Patients With Type 2 Diabetes Mellitus and Heart Failure”. 2020. Electronic Journal Collection Health 12 (9): e4349. https://doi.org/10.25248/reas.e4349.2020.